Q3 2021 Holdings
Filed 2021-11-15 | 33 holdings | $204.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $172.6M | 7,648,268 | 84.6% |
| Biocryst Pharmaceuticals Inc.(BCRX) | Common | 09058V103 | $10.1M | 704,767 | 5.0% |
| Cytokinetics Inc.(CYTK) | Common | 23282W605 | $8.8M | 247,291 | 4.3% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $6.3M | 298,392 | 3.1% |
| Axsome Therapeutics Inc.(AXSM) | Common | 05464T104 | $3.6M | 110,155 | 1.8% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $2.1M | 248,506 | 1.0% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $56.9K | 2,107,092 | 0.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $43.0K | 1,639,849 | 0.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $41.0K | 2,388,011 | 0.0% |
| MEI Pharma, Inc. | Common | 552798202 | $34.5K | 12,494,118 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $28.7K | 3,370,982 | 0.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $25.3K | 3,196,707 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $22.2K | 2,377,031 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $21.8K | 162,620 | 0.0% |
| Merus N.V. | Common | N5749R100 | $20.7K | 941,948 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $20.3K | 3,972,830 | 0.0% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $18.0K | 271,350 | 0.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $12.9K | 452,970 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $11.5K | 860,502 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $9.4K | 344,519 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $8.7K | 2,824,857 | 0.0% |
| Geron Corporation(GERN) | Common | 374163103 | $7.9K | 5,732,770 | 0.0% |
| Travere Therapeutics Inc.(TVTX) | Common | 89422G107 | $7.4K | 306,515 | 0.0% |
| Neogenomics Inc.(NEO) | Common | 64049M209 | $7.2K | 149,504 | 0.0% |
| Mirum Pharmaceuticals Inc.(MIRM) | Common | 604749101 | $6.1K | 308,532 | 0.0% |
| Harmony Biosciences Hldgs Inc.(HRMY) | Common | 413197104 | $5.8K | 151,650 | 0.0% |
| Essa Pharma, Inc.(EPIEUR) | Common | 29668H708 | $5.5K | 683,287 | 0.0% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $5.2K | 546,558 | 0.0% |
| Avrobio, Inc. | Common | 05455M100 | $4.8K | 861,858 | 0.0% |
| Lucira Health Inc. | Common | 54948U105 | $4.4K | 578,114 | 0.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $4.1K | 150,000 | 0.0% |
| Avadel Pharmaceuticals Plc | Common | 05337M104 | $3.9K | 400,000 | 0.0% |
| Inozyme Pharma Inc. | Common | 45790W108 | $3.7K | 320,724 | 0.0% |